Innovation and strategies for pharmas, biotechs and the R&D community
BioPharma: Tuesday, April 17, 2012
Please enable javascript to see more information on speakers
| 8am | Registration and coffee | ||
| 8.50am | Chairperson's opening remarks | ||
Economic growth for pharmaceuticals in Latin America | |||
| 9am |
Regional financial performance and future growth protential
| ||
Market access: Brazil | |||
| 9.25am |
Capitalizing on Latin America's monumental pharmaceutical growth
| ||
| 9.50am |
Partnering with ANVISA to decrease regulatory holdups in Brazil
| ||
| 10.15am | Speed networking | ||
| 10.45am | Networking coffee break | ||
Market access: LatAm | |||
| 11.15am | Regulatory affairs and its impact in market access in Latin America | ||
| 11.40am |
Venezuela case study: political climate and its affect on the pharma industry
| ||
| 12.05pm | Networking lunch | ||
Overcoming logistical access challenges | |||
| 1.05pm |
Panel: dividing resources to capitalize on both generic drugs and novel technologiesModerator: Mariana SandroniPossui graduação em Ciências Biológicas pela Universidade do Estado do Rio de Janeiro, mestrado em Genética Molecular Vegetal pela Universidade Federal do Rio de Janeiro e pós em Gestão Ambiental pela Coppe/UFRJ. Tem experiência em pesquisa e... more..  Derek KostiDerek Kosti is the Worldwide Biopharmaceutical Business Controller - International for Pfizer Inc. In this role, Derek is responsible for ensuring the integrity of financial reporting, enhancing the control environment and reviewing all... more.. Dirceu BarbanoGraduado em Ciências Farmacêuticas pela PUC-Campinas. Foi professor na Faculdade de Farmácia da PUC-Campinas nos anos de 1990 e 2000. Foi Conselheiro do CFF em 1992. Diretor Vice-Presidente e depois Presidente do CRF do Estado de São Paulo, entre... more.. Fabio MataveliFabio Mataveli holds a MD from the State University of Campinas (UNICAMP), a PhD in Gene Therapy from the Federal University of São Paulo (UNIFESP), a MBA in Finance from Fundação Getulio Vargas (FGV) and a Specialization in Health Economics from... more.. | ||
| 1.40pm |
IP rights in LatAm: understanding the legal realities for pharma companies
| ||
| 2.30pm |
Panel: strategic considerations for LatAm pharma partnerships  Rodrigo CrispimRodrigo Crispim is the Brazil Regional Clinical Operations Hub Unit Manager with eight years of clinical research experience at Bristol-Myers Squibb. He worked as protocol manager in Lawrenceville, NJ for during the last 6 months from 2010 and... more.. Weining MengMr. Weining Meng is the senior manager of international marketing of Sinovac Biotech Co., Ltd, listed in Nasdaq as the code of “SVA”. Weining Meng has obtained the engineering bachelor from China Pharmaceutical University in 2001 and the science... more.. Juan Manuel Pinto-Ribeiro CorreaExperiencias en diferentes mercados / segmentos, tales como bebidas, cosméticos, alimentos, productos infantiles y medicamentos “populares (OTC’s”), habiendo vivido en México, Estados Unidos y Brasil. Participé y comandé varias actividades de... more.. Paulo Roberto de CarvalhoBachelor with a degree in Chemistry (Unesp - Universidade Estadual Paulista, 1993), bachelor in Chemical Technology (Unesp, 1994), master's degree (Unesp, 1997) and doctorate in Chemistry (Unesp, 2002), in the area of Organic Chemistry, subarea... more..
| ||
| 3.05pm | Networking coffee break | ||
Identifying key stakeholders for regional partnerships | |||
| 3.35pm |
Public-Private partnerships with LatAm governments
| ||
| 4pm |
Case study: allying with local biotechs for local LatAm distribution
| ||
| 4.25pm |
Case study: licensing with local biotechs for local LatAm distribution
| ||
| 4.50pm |
Case study: working with academics to source and develop emerging technology
| ||
| 5.15pm |
Partnering with the right CROs to navigate local challenges in clinical trials
| ||
| 5.40pm | Close of day one followed by networking drinks |
